Roidipedia.Compound reference & reporting
05 AUG 2026
CompoundsPharmaceutical Estradiol Enanthate
PharmaceuticalInjectableEstrogenEstradiol ester

Estradiol Enanthate

Also known as EEn · Perlutal (component) · Topasel (component)

Long-acting injectable estradiol ester, historically paired with dihydroxyprogesterone acetophenide in the monthly injectable contraceptive Perlutal/Topasel. Provides extended estradiol release for HRT and feminization.

01 Overview

Estradiol enanthate is a slow-release ester of 17-beta-estradiol. Its best-documented use is as the estrogen component of once-monthly combined injectable contraceptives popular in Latin America. It is also used in feminizing hormone therapy where a long dosing interval is desired.

Because data in transfeminine care come largely from smaller series and contraceptive literature, dosing is individualised and monitored by serum estradiol.

02 Mechanism

Enanthate ester hydrolyses to 17-beta-estradiol, activating estrogen receptors and suppressing the HPG axis.

03 Dosing

TierDoseRouteNotes
Feminizing HRT3–10 mg/wkIMGiven every 1-2 weeks; titrate to serum estradiol.

04 Effects

EffectMagnitudeEvidence
FeminizationBreast development and fat redistribution as with other estradiol esters.Observational
Long dosing intervalExtended release allows less frequent injection.Observational

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Venous thromboembolismClass estrogen clotting risk.SevereUncommonClinical
Estradiol overshootLong ester makes correcting high levels slow.ModerateCommon with large depotsObservational

07 References

Once-a-month combined injectable contraceptives: efficacy and reasons for discontinuation (WHO)Contraception, WHO trials

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.